en

PRODUCT DETAIL

IBRANCE 75 mg filmom obalené tablety

Code 5484D
MA number EU/1/16/1147/016
Product Form: tbl flm 21x75 mg (blis.PVC/OPA/Al/PVC/Al + puzdro)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Pfizer Europe MA EEIG, Belgium
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EF Cyclin-dependent kinases (CDK) inhibitors
L01EF01 Palbociclib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 26.06.2020
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 25.05.2023
eu-flag.png sk-flag.png